A short introduction to Amferia as presented at Brilliant Minds 2019, Stockholm
Amferia AB is a Swedish Med-Tech Company founded in 2018 and is located in Gothenburg, Sweden. Amferia’s proprietary technology is a result of several years of research and is patent protected. Our team consists of scientists, inventors, entrepreneurs and visionaries.
ANAND KUMAR RAJASEKHARAN
CEO & Co-founder
Anand is a scientist and entrepreneur who is driven to bring new life-science technologies for improving human health. Anand holds a PhD in Materials Science from Chalmers University of Technology and is the inventor of the material platform serving Amferia’s healthcare technology. Anand is the inventor of two patents and has published in high impact scientific journals such as Advanced Materials and Nature Communications. Today, he leads Amferia’s business and technical development portfolio.
CTO & Co-founder
Saba is a passionate entrepreneur and scientist. Saba holds a MSc. in Materials Science and currently pursuing her PhD in Materials Science at Chalmers University of Technology. Saba is the inventor of the antibacterial platform serving Amferia’s technology. Saba has published her work in high impact scientific journals such as Acta Biomaterialia and has in-depth knowledge on the IP sector of the technology. Today, she leads Amferia’s antibacterial and product design portfolio.
Scientific Advisor & Co-founder
An entrepreneur and academic with long experience, Martin’s vision is to bring innovative medical technology to positively impact human lives. Martin is Professor of Materials Science at Chalmers University and Chairman of Amferia AB. Martin has over 10 years’ experience in medical device research and antibacterial materials with nearly 100 scientific publications in prestigious journals such as Nature Communications, Advanced Materials and Nano Letters. He has also previously started-up a biomaterials company for bone and dental implants with successful implementation of products into the market and in patients. Martin has strong background with strategies for regulatory filing, IP, scale-up and marketing and he possesses expert knowledge on fundamental science and prototyping work for device development.
Annija is a materials chemist adept at biomedical research through design and evaluation of new, medically relevant materials. Annija holds a MSc. in Materials Chemistry and currently is pursuing a PhD in Material Science at Chalmers University of Technology. Annija has a strong background in biomaterial science and technology covering various material classes and functionalities. At Amferia she handles material testing and biological evaluation along with new process technology progression, facilitating Amferia’s core product development.
Edvin is a highly-skilled bioengineer who is an expert in material design and antimicrobial technology and cell-material assessment. Edvin has a MSc degree in Biotechnology from Chalmers University of Technology. At Amferia, Edvin drives the product design and device optimization. Edvin has strong experience working with some of the most resistant bacterial strains.
Partners & Funding